Health

Results: 1093-1104 of 8109

Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

BeOne Medicines Announces Third Quarter 2025 Financial Results and Business Updates

Samsung Bioepis Reaches Settlement Agreement for PYZCHIVA® (ustekinumab) in Europe

PR Newswire associated0

THE ADECCO GROUP Q3 2025 RESULTS

PR Newswire associated0

138th Canton Fair: Rising Demand for At-Home Healthcare Spurs Innovation in Smart Rehab and Wellness Tech

10X Health and REVIV Global Announce Strategic Partnership with M42 to Launch 10XREVIV in Abu Dhabi

PR Newswire associated0

The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia

PR Newswire associated0

Jazz Pharmaceuticals Announces Third Quarter 2025 Financial Results and Updates 2025 Financial Guidance

Sobi to present New One-Year Data on pegcetacoplan's efficacy in C3G and primary IC-MPGN and new outcome data on NASP at ASN Kidney Week

Imricor’s NorthStar® Mapping System

First in Human Ischemic VT Ablation Successfully Performed in iCMR

SIS Medical AG Welcomes the Results of the VICTORY Trial Demonstrating Non-inferiority of OPN NC to Intravascular Lithotrispy (IVL) for Lesion Preparation and Stent Expansion in Severely Calcified Lesions

Santen Receives UK Approval for Ryjunea® (low-dose atropine 0.1 mg/ml) to Slow Progression of Childhood Myopia